To Compare the Effectiveness of Percutaneous Nephrostomy Versus Double-J Stent in Obstructive Uropathy

Authors

  • Ishtiaq Ur Rehman Khyber Teaching Hospital, Peshawar
  • Murad Ali Khyber Teaching Hospital, Peshawar
  • Adil Muhammad Khyber Teaching Hospital, Peshawar
  • Muhammad Danish Khyber Teaching Hospital, Peshawar
  • Asghar Ali Khyber Teaching Hospital, Peshawar
  • Syed Abdul Basit Ali Shah Khyber Teaching Hospital, Peshawar
  • Pir Sabir Shah Khyber Teaching Hospital, Peshawar

Keywords:

Obstructive Uropathy, Percutaneous Nephrostomy, Double-J Stent, Prospective Cohort, Urinary Drainage, Effectiveness

Abstract

ABSTRACT

OBJECTIVES

This study aimed to compare the short-term effectiveness of percutaneous nephrostomy and double-J ureteral stenting in patients with obstructive uropathy.

METHODOLOGY

This retrospective observational study was conducted at Rehman Medical Institute, Peshawar, from January to December 2024. All positive blood cultures during the study period were processed using standard microbiological techniques and the Vitek 2.0 system. Antimicrobial susceptibility testing was performed according to Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2024 guidelines. Organisms were categorized as per standard resistance classification. Data were analyzed in SPSS v27, with p<0.05 considered significant.

RESULTS
Mean age was 35.6 ± 8.4 years, and 76.7% of participants were male. Treatment effectiveness was higher with percutaneous nephrostomy than with double-J stenting (88.5% vs 77.9%, p = 0.004). After adjustment, percutaneous nephrostomy remained associated with higher odds of success (adjusted odds ratio 2.05, 95% confidence interval 1.18 to 3.55, p = 0.01). Female sex and malignant etiology were independently associated with lower treatment success. Procedure time and hospital stay were similar between groups.

CONCLUSION

Percutaneous nephrostomy was associated with higher short-term treatment effectiveness than double-J stenting in obstructive uropathy. Clinical context and underlying etiology should guide treatment selection.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Ishtiaq Ur Rehman, Khyber Teaching Hospital, Peshawar

Senior Registrar,
Department of Urology,
Khyber Teaching Hospital, Peshawar

Murad Ali, Khyber Teaching Hospital, Peshawar

Post Graduate Resident,
Department of Urology,
Khyber Teaching Hospital, Peshawar

Adil Muhammad, Khyber Teaching Hospital, Peshawar

Post Graduate Resident,
Department of Urology,
Khyber Teaching Hospital, Peshawar

Muhammad Danish, Khyber Teaching Hospital, Peshawar

Post Graduate Resident,
Department of Urology,
Khyber Teaching Hospital, Peshawar

Asghar Ali, Khyber Teaching Hospital, Peshawar

Post Graduate Resident,
Department of Urology,
Khyber Teaching Hospital, Peshawar

Syed Abdul Basit Ali Shah, Khyber Teaching Hospital, Peshawar

Post Graduate Resident,
Department of Urology,
Khyber Teaching Hospital, Peshawar

Pir Sabir Shah, Khyber Teaching Hospital, Peshawar

Post Graduate Resident,
Department of Urology,
Khyber Teaching Hospital, Peshawar

References

Pérez-Aizpurua X, Cabello Benavente R, Bueno Serrano G, Alcázar Peral JM, Gómez-Jordana Mañas B, Tufet i Jaumot J, et al. Obstructive uropathy: overview of the pathogenesis, etiology and management of a prevalent cause of acute kidney injury. World J Nephrol. 2024;13(2):93322. https://doi.org/10.5527/wjn.v13.i2.93322 PMID: 38648733 PMCID: PMC11034074

European Association of Urology. EAU guidelines on urolithiasis. Arnhem (NL): EAU Guidelines Office; 2025

Bingaman S, Leslie SW, Hinson MR. Obstructive uropathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Updated 2025 Nov 7

Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018;5(4):205-214. https://doi.org/10.1016/j.ajur.2018.08.007 PMID: 30310968 PMCID: PMC6177270

Zul Khairul Azwadi I, Norhayati MN, Abdullah MS. Percutaneous nephrostomy versus retrograde ureteral stenting for acute upper obstructive uropathy: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6613. https://doi.org/10.1038/s41598-021-86136-y PMID: 33758268 PMCID: PMC7988020

Fischer KM, Louie M, Mucksavage P. Ureteral stent discomfort and its management. Curr Urol Rep. 2018;19(8):64. https://doi.org/10.1007/s11934-018-0818-8 PMID: 30062655

Radecka E, Magnusson A. Complications associated with percutaneous nephrostomies: a retrospective study. Acta Radiol. 2004;45(2):184-188. https://doi.org/10.1080/02841850410003671 PMID: 15204319

Moon YJ, Jun DY, Jeong JY, Cho S, Lee JY, Jung HD. Percutaneous nephrostomy versus ureteral stent for severe urinary tract infection with obstructive urolithiasis: a systematic review and meta-analysis. Medicina (Kaunas). 2024;60(6):861. https://doi.org/10.3390/medicina60060861 PMID: 38930539 PMCID: PMC11246501

Cardoso A, Coutinho A, Neto G, Anacleto S, Tinoco CL, Morais N, et al. Percutaneous nephrostomy versus ureteral stent in hydronephrosis secondary to obstructive urolithiasis: a systematic review and meta-analysis. Asian J Urol. 2024;11(2):261-270. https://doi.org/10.1016/j.ajur.2023.03.007 PMID: 37080201

Ahmad MU, Siddiqui S, Ashraf FA, Khan MS, Somani BK, Nabi G, et al. Retrograde ureteral stents versus percutaneous nephrostomy in the management of malignant ureteral obstruction: a systematic review and meta-analysis. Urology. 2024;192:158-167. https://doi.org/10.1016/j.urology.2024.05.042 PMID: 38831148

Wang X, Ji X. Sample size estimation in clinical research: from randomized controlled trials to observational studies. Chest. 2020;158(1 Suppl):S12-S20. https://doi.org/10.1016/j.chest.2020.03.010 PMID: 32658663.

Ahmad I, Pansota MS, Tariq M, Saleem MS, Tabassum SA, Hussain A. Comparison between double-J ureteral stenting and percutaneous nephrostomy in obstructive uropathy. Pak J Med Sci. 2013;29(3):725-729. https://doi.org/10.12669/pjms.293.3563 PMID: 24353646 PMCID: PMC3809319

Shah M, Blest F, Blackmur J, Laird A, Dawson S, Aning J. Malignant upper urinary tract obstruction in cancer patients: a systematic review. BJUI Compass. 2024;5(5):405-416. https://doi.org/10.1002/bco2.340 PMID: 38940741 PMCID: PMC11251049

Ali AS, Mahnoor A, Basharat MA, Bilal M, Abrar M, Liaqat K. Percutaneous nephrostomy audit: evaluating quality and technical proficiency. J Bahria Univ Med Dent Coll. 2025;15(4):389-392

Heo JE, Jeon DY, Lee J, Han HH, Jang WS. Prediction of stent failure for malignant ureteral obstruction in non-urological cancer. Yonsei Med J. 2023;64(11):665-669. https://doi.org/10.3349/ymj.2023.0117 PMID: 37730333 PMCID: PMC10571561

Chitale SV, Scott-Barrett S, Ho ETS, Burgess NA. The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol. 2002;57(12):1118-1121. https://doi.org/10.1053/crad.2002.1046 PMID: 12475535

Gebreselassie KH, Adamu TA, Beyene AD. Ureteral stenting in patients with locally advanced cervical cancer: predictors of low success rate. Gynecol Oncol Rep. 2024;55:101491. https://doi.org/10.1016/j.gore.2024.101491 PMID: 39051674 PMCID: PMC11271139

Shvero A, Haifler M, Mahmud H, Dotan ZA, Winkler H, Kleinmann N. Quality of life with tandem ureteral stents compared to percutaneous nephrostomy for malignant ureteral obstruction. Support Care Cancer. 2022;30(11):9541-9548. https://doi.org/10.1007/s00520-022-07354-2 PMID: 35997861

Downloads

Published

2026-04-01

How to Cite

Ur Rehman, I. ., Ali, M., Muhammad, A., Danish, M., Ali, A. ., Ali Shah, S. A. B., & Shah, P. S. (2026). To Compare the Effectiveness of Percutaneous Nephrostomy Versus Double-J Stent in Obstructive Uropathy. Journal of Gandhara Medical and Dental Science, 13(2), 65–70. Retrieved from http://jgmds.org.pk/index.php/JGMDS/article/view/847